We showed that AKT1 expression is significantly upregulated in prostate cancer samples compared to normal prostate tissue (Figure 2d) and in tumors with a higher Gleason score (Figure 2e), trends that are the inverse of the miR-143-3p expression profile in these samples. Here, AKT1 is linked to prostate cancer.